Go Pro

Nano-X Imaging (NNOX) to Post Quarterly Earnings on Tuesday

Nano-X Imaging logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Nano-X Imaging is expected to report quarterly results before the market opens Tuesday, August 11. Analysts forecast a loss of $0.1633 per share and revenue of approximately $5.39 million, compared with the prior quarter’s $0.16 loss and $4.31 million in revenue.
  • The company remains financially challenged, with a negative 716.44% net margin and 70.96% negative return on equity. Shares recently traded near $1.09, well below their 52-week high of $4.95.
  • Analyst sentiment is mixed, with a “Moderate Buy” consensus and an average price target of $4.00, while insiders recently purchased shares at $0.93 each. Institutional investors and hedge funds own about 21.49% of the stock.
  • MarketBeat previews the top five stocks to own by September 1st.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) will likely be issuing its results before the market opens on Tuesday, August 11th. Analysts expect the company to announce earnings of ($0.1633) per share and revenue of $5.3850 million for the quarter.

Nano-X Imaging (NASDAQ:NNOX - Get Free Report) last released its quarterly earnings results on Thursday, June 25th. The company reported ($0.16) earnings per share for the quarter. The firm had revenue of $4.31 million during the quarter. Nano-X Imaging had a negative return on equity of 70.96% and a negative net margin of 716.44%. On average, analysts expect Nano-X Imaging to post $-1 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Nano-X Imaging Price Performance

NNOX traded down $0.01 during trading on Tuesday, reaching $1.09. 388,845 shares of the stock were exchanged, compared to its average volume of 1,602,809. The company has a market capitalization of $76.21 million, a price-to-earnings ratio of -0.69 and a beta of 1.27. Nano-X Imaging has a 1 year low of $0.73 and a 1 year high of $4.95. The business's 50 day moving average price is $1.40 and its two-hundred day moving average price is $2.02.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the stock. Zacks Research raised shares of Nano-X Imaging from a "strong sell" rating to a "hold" rating in a research note on Monday, June 22nd. Alliance Global Partners cut shares of Nano-X Imaging from a "buy" rating to a "neutral" rating and cut their target price for the stock from $5.00 to $3.00 in a research report on Tuesday, July 7th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Nano-X Imaging in a report on Wednesday, July 8th. Finally, D. Boral Capital reiterated a "buy" rating and issued a $5.00 price target on shares of Nano-X Imaging in a research report on Monday, April 20th. Two analysts have rated the stock with a Strong Buy rating, one has given a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Nano-X Imaging currently has an average rating of "Moderate Buy" and an average price target of $4.00.

View Our Latest Stock Analysis on NNOX

Insider Activity

In other news, Director Dan S. Suesskind purchased 50,000 shares of the stock in a transaction dated Monday, July 27th. The stock was acquired at an average cost of $0.93 per share, for a total transaction of $46,500.00. Following the completion of the acquisition, the director directly owned 50,000 shares in the company, valued at $46,500. This represents a ∞ increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Erez Meltzer acquired 36,000 shares of the business's stock in a transaction dated Monday, July 27th. The stock was purchased at an average cost of $0.93 per share, with a total value of $33,480.00. Following the transaction, the chief executive officer owned 36,000 shares of the company's stock, valued at approximately $33,480. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing.

Institutional Trading of Nano-X Imaging

Hedge funds have recently added to or reduced their stakes in the business. Weiss Asset Management LP acquired a new position in shares of Nano-X Imaging during the 4th quarter valued at about $8,424,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Nano-X Imaging by 232.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,160,806 shares of the company's stock worth $10,793,000 after buying an additional 1,510,806 shares during the period. State Street Corp raised its position in shares of Nano-X Imaging by 1.2% in the 4th quarter. State Street Corp now owns 1,176,202 shares of the company's stock worth $3,293,000 after buying an additional 14,422 shares during the period. UBS Group AG boosted its holdings in Nano-X Imaging by 68.8% in the third quarter. UBS Group AG now owns 1,086,645 shares of the company's stock valued at $4,021,000 after acquiring an additional 442,899 shares during the last quarter. Finally, Geode Capital Management LLC grew its position in Nano-X Imaging by 4.8% during the fourth quarter. Geode Capital Management LLC now owns 824,594 shares of the company's stock valued at $2,309,000 after acquiring an additional 37,436 shares during the period. 21.49% of the stock is owned by institutional investors and hedge funds.

Nano-X Imaging Company Profile

(Get Free Report)

Nano-X Imaging Ltd. is a medical technology company developing and commercializing a digital X-ray imaging platform designed to lower the cost and increase the accessibility of diagnostic imaging. Its flagship product, the Nanox.ARC, leverages a proprietary micro-electromechanical system (MEMS) based digital X-ray source and advanced image processing software to provide 2D and 3D imaging capabilities on a compact footprint. The system aims to streamline radiology workflows and facilitate point-of-care diagnostics in hospitals, clinics and outpatient settings.

The Nanox.ARC platform integrates a novel cold cathode X-ray source, which enables multiple emission points without the need for rotating anode tubes.

Featured Articles

Earnings History for Nano-X Imaging (NASDAQ:NNOX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nano-X Imaging Right Now?

Before you consider Nano-X Imaging, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nano-X Imaging wasn't on the list.

While Nano-X Imaging currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines